Drug Audits Of 340B Providers Will Be Both Random And Targeted, HRSA Says

The Health Resources and Services Administration has begun random and targeted audits of health care providers participating in the federal 340B drug discount program to help ensure products are not being diverted for other uses or resulting in manufacturers paying double discounts to Medicaid.

More from Market Access

More from Pink Sheet